Evidence map›Paper›PMID 31937723›Full record

ArticleIndian journal of ophthalmology2020

Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus.

Taraprasad Das, Umesh C Behera, Harsha Bhattacharjee, Clare Gilbert, G V S Murthy, Ramachandran Rajalakshmi, Hira B Pant, Rajan Shukla, SPEED Study group

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Taraprasad DasSrimati Kanuri Santamma Centre for Vitreoretinal diseases, L V Prasad Eye Institute, Hyderabad, India.
Umesh C BeheraDepartment of Retina and Vitreous, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.
Harsha BhattacharjeeDepartment of Retina and Vitreous, Sri Sankaradeva Nethralaya, Guwahati, India.
Clare GilbertLondon School of Hygiene and Tropical Medicine, London, UK.
G V S MurthyIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, India.
Ramachandran RajalakshmiDepartment of Ophthalmology, Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India.
Hira B PantIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, India.
Rajan ShuklaIndian Institute of Public Health, Public Health Foundation of India, Hyderabad, India.
SPEED Study group
L V Prasad Eye Institute · INLondon School of Hygiene & Tropical Medicine · GBPublic Health Foundation of India · INSankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To document the spectrum of eye diseases in people with type 2 diabetes mellitus (T2DM) reporting to large eye care facilities in India. Methods: The selection of eye care facilities was based on the zone of the country and robustness of the programs. Only people with known T2DM certified by internist, or taking antidiabetes medications, or referred for diabetes related eye diseases were recruited. The analysis included the demographic characteristics, systemic associations, ocular comorbidities, and visual status. Results: People (11,182) with T2DM were recruited in 14 eye care facilities (3 in north, 2 in south central, 4 in south, 2 in west, and 3 in east zone); two were government and 12 were non-government facilities. Hypertension was the commonest systemic association (n = 5500; 49.2%). Diabetic retinopathy (n = 3611; 32.3%) and lens opacities (n = 6407; 57.3%) were the common ocular disorders. One-fifth of eyes (n = 2077; 20.4%) were pseudophakic; 547 (5.4%) eyes had glaucoma and 277 (2.5%) eyes had retinal vascular occlusion. At presentation, 4.5% (n = 502) were blind (visual acuity < 3/60 in the better eye) and 9.6% (n = 1077) had moderate to severe visual impairment (visual acuity <6/18-->3/60 in the better eye). Conclusion: People with T2DM presenting at eye clinics in India have high rates of diabetic retinopathy and vision loss. Cataract is a very common occurrence. Advocacy, infrastructure strengthening, and human resource development are the key to address the growing threats of T2DM and eye care in India.

Indexed as

Visual AcuityAdultAgedAged, 80 and overDiabetes Mellitus, Type 2FemaleHumansIncidenceIndiaMaleMiddle AgedPrognosisVision DisordersClinic populationdiabeteseye disordersIndia

Identifiers

PMID31937723
PMCPMC7001179
OpenAlexW3000483075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.